GREY:IPHAF - Post by User
Comment by
snrkidon Apr 03, 2009 4:53pm
592 Views
Post# 15895642
RE: UB Voclosporin Psoriasis Report - Dec/08
RE: UB Voclosporin Psoriasis Report - Dec/08Good report. Shows how Voclosporine has demonstrated advantage comparing to market leaders. Hope present trial confirms results.
last few days of trading by UBS makes one wonder if they have been hired by someone to slam the ISA share price down for some reason. Even UBS traders can't be as stupid as latest trades show.
I Think Isotechnika board of directors should put in place a poison pill, for example in case of take-over to issue every present shareholder 10 times of total held at December 31. /08 closing price exercizable for two years.
have a great weekend....
snrkid.